Prostate cancer is one of the leading causes of cancer death in the US. It is also the most common cause of cancer among men, according to the Centers for Disease Control. That said, most men survive prostate cancer. Virtually all men survive for several years, with 98 percent surviving for 10 years, and 96 percent surviving for at least 15 years. The five-year survival rate falls to 29 percent for men with prostate cancer that has spread to other parts of the body. Should you be screened for prostate cancer?
Should you get a prostate cancer screening?
The US Preventive Services Task Force (USPSTF) advises that men between the ages of 55 and 69 should decide for themselves whether to get a prostate-specific antigen (PSA)-based screening for prostate cancer. They should consult with their physicians about the risks and benefits and factor in their preferences in their decision.
The USPSTF says that screening offers a small possible benefit of lowering the risk of death from prostate cancer for men between 55 and 69. It also says that screening can cause many harms, including extra testing and perhaps prostate biopsy, as well as overtreatment. Overtreatment can lead to incontinence and erectile dysfunction.
As a result, the USPSTF gives the prostate cancer screening a “C” grade, meaning that there is “at least moderate certainty that the net benefit is small.” And, for men who are 70 or older, it gives the screening a “D” grade, recommending against it because “there is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits..”
Why shouldn’t I get a prostate cancer screening?
The Prostate-Specific Antigen (PSA) blood test cannot differentiate between cancers that will be aggressive and benign cancers that are slow-growing and will never produce symptoms. Even so, most people with prostate cancer (aggressive or otherwise), never have symptoms. Invasive treatments for prostate cancer, like chemotherapy and radiation, in people with a benign slow-growing form are likely to cause significant harm.
The Prostate Cancer Foundation reports that as many as two in five men treated for prostate cancer had tumors that would never have presented a risk to their health or lives. But, the radiation treatment many men opt for can cause incontinence and erectile dysfunction. And, hormone therapy treatment can lead to depression and osteoporosis.
On the other hand, screening could reduce the chance of death from prostate cancer. The medical community recommends shared decision-making around screening. Individuals should weigh the risks and benefits of screening and make an informed decision on whether to proceed.
What does Medicare cover?
If you decide to proceed with a prostate cancer screening, Medicare covers a prostate screening each year, including a Prostate-Specific Antigen (PSA) blood test and a digital rectal exam (DRE). If you have traditional Medicare and your doctor takes assignment, the PSA test is covered in full. If you are enrolled in a Medicare Advantage plan, it is also covered in full if you see an in-network doctor. You will be responsible for coinsurance or a copay with the digital rectal exam.
Medicare covers these tests more frequently for people whose doctors say they are medically necessary for diagnostic purposes.
Here’s more from Just Care:
- Get the preventive care you need: Medicare pays for it
- Seven things to do before you or someone you love leaves the hospital
- Plan ahead for a hospital visit: Talk to the people you love about these seven important items
- Programs that lower your costs if you have Medicare
- Question your doctor before getting arthroscopic knee surgery